SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: MIKE DUBIS who wrote (9115)5/23/1998 10:31:00 AM
From: BDR  Respond to of 18691
 
<<negative on ENMD>>

Agree. The public believes that the NY Times is better at assessing the therapeutic potential of new anti-cancer drugs than medical oncologists. The info is not new. But then the market's perception of value is what sets a stock's price. I see nothing that will change that perception until some patients actually get treated with the drugs which is supposed to happen on a small scale later this year.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News